Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early eMDR Adopters Share Tips On High-, Low-Volume Systems

This article was originally published in The Gray Sheet

Executive Summary

Whether they file 500 Medical Device Reports a year or five, device companies new to electronic MDR reporting should get their feet wet with FDA's eSubmitter and Web Trader tools, industry reps say

You may also be interested in...



eMDR 101: Experts Show Companies The e-Submissions Ropes

Though the date to comply with FDA's new electronic adverse event reporting requirements is still some time away, groups are already gearing up to guide firms through the complex new process

Device Firms Want Two Years To Comply With Electronic MDR Rule

Covidien, AdvaMed and the Medical Imaging and Technology Alliance are asking FDA to give device manufacturers two years to comply with an upcoming rule requiring adverse event reports to be submitted to the agency electronically

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel